Use of [177Lu]Lu-DOTA-TATE in the treatment of gastroenteropancreatic neuroendocrine tumours: Results of a UK cost-effectiveness modelling study

Matthew Glover,Martyn Caplin,Oscar R Leeuwenkamp,Louise Longworth

European Journal of Cancer Supplements（2021）

引用 3|浏览1

暂无评分

摘要

•A three-state partitioned survival model of GEP-NET patients was developed.•Base case ICERs for [177Lu]Lu-DOTA-TATE were under £30,000 per QALY for all comparators.•[177Lu]Lu-DOTA-TATE is cost-effective for the treatment of GEP-NETs from a NICE perspective.

查看译文

关键词

Gastro-enteropancreatic neuroendocrine tumours (GEP-NETs),177Lu-DOTA-octreotate,[177Lu]Lu-DOTA-TATE,Everolimus,Sunitinib,Quality-Adjusted Life Years (QALYs)

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要